Olenox Acquires Psylinks Neurotech in All-Stock Deal, Expanding Into Brain-Tech
OLOX sits 38% above its 52-week low of $4.1.
Summary
Olenox Industries signed a stock-for-stock deal on July 3 to acquire Psylinks Neurotech, marking a push into neurotechnology. The agreement, disclosed in an 8-K today, follows a turbulent period: a subsidiary's Chapter 11 filing in May, a 1-for-10 reverse split, and a going-concern warning in the June 10-K. The company recently closed the CS Digital Ventures acquisition, which brought Bitcoin mining assets, and dismissed its CFO in June. This neurotech move diversifies beyond digital infrastructure but adds to a complex restructuring story. No financial terms were disclosed, leaving the dilution impact unclear. The deal's strategic value hinges on Psylinks' technology and integration execution amid Olenox's financial strain.
At the time of this announcement, OLOX was trading at $5.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $4.10 to $437.06. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.